Skip to main content
profile image
Selected Works of Laura Greiss Hess
Presentation
Effects of Sertraline Treatment for Young Children with FXS
American Academy of Pediatrics (AAP) National Conference
  • Andrew Ligsay, MIND Institute, University of California, Davis
  • Laura Greiss Hess, Department of Occupational Therapy, Dominican University of California
  • Sarah Fitzpatrick, MIND Institute, University of California,Davis
  • Kerrie Lemons Chitwood, MIND Institute, University of California,Davis
  • Jonathan Polussa, MIND Institute, University of California,Davis
  • Salpi Siyahian, MIND Institute, University of California,Davis
  • Randi Hagerman, MIND Institute, University of California,Davis
Download
Document Type
Conference Proceeding
Location
San Francisco, CA
Publication Date
10-1-2015
Disciplines
Department
Occupational Therapy
Abstract

Selective serotonin reuptake inhibitors (SSRIs) help treat many of the phenotypic manifestations of fragile X syndrome (FXS) including anxiety, sensory processing challenges, and communication and intellectual deficits. However, the efficacy of SSRIs has not been previously studied in children with FXS under five-years-old. The purpose of this study was to elucidate group differences in behavior and developmental outcome measures for young children with FXS when treated with sertraline compared to placebo.

Comments

Presented at the American Academy of Pediatrics (AAP) National Conference, San Francisco, CA

Citation Information
Andrew Ligsay, Laura Greiss Hess, Sarah Fitzpatrick, Kerrie Lemons Chitwood, et al.. "Effects of Sertraline Treatment for Young Children with FXS" American Academy of Pediatrics (AAP) National Conference (2015)
Available at: http://works.bepress.com/laura_greisshess/36/